What is the generic name for Lo Loestrin Fe?
The generic name for Lo Loestrin Fe is norethindrone acetate and ethinyl estradiol chewable tablets [1].
When can generic versions of Lo Loestrin Fe be expected?
The patent expiration for Lo Loestrin Fe is scheduled for 2033 [2]. However, patent challenges can lead to earlier generic entry [3]. For example, in 2023, a patent for Lo Loestrin Fe was found invalid in court, potentially opening the door for generics sooner than the listed expiration date [3].
What are the active ingredients in Lo Loestrin Fe?
Lo Loestrin Fe contains two active ingredients: norethindrone acetate, a progestin, and ethinyl estradiol, an estrogen [1].
How do generic birth control pills differ from brand-name ones?
Generic versions of oral contraceptives are required to contain the same active ingredients as the brand-name drug [4]. They are also expected to have the same dosage, strength, safety, and effectiveness [4]. The main difference is typically in the inactive ingredients, such as fillers, binders, and dyes, which can sometimes lead to variations in how a patient tolerates the medication [4].
What is the typical price difference between brand-name and generic Lo Loestrin Fe?
Generally, generic medications are significantly less expensive than their brand-name counterparts [5]. While specific pricing varies, patients often see substantial cost savings by opting for the generic version once it becomes available [5].
Who manufactures Lo Loestrin Fe and its potential generics?
Lo Loestrin Fe is manufactured by AbbVie [6]. The manufacturers of potential generic versions would be pharmaceutical companies that successfully challenge existing patents or wait for them to expire [3][5].